🔎 Trials Near Me

Hjem › Bronkialkreft › Virginia

Kliniske studier for Bronkialkreft i Virginia

4 studier for Bronkialkreft søker deltakere på steder i Virginia.

Byer i Virginia

Offisiell studietekst (engelsk)

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

  • NEXT Oncology Virginia, Fairfax
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 22. sep. 2026 · NCT06128551

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

  • University of Virginia Health System, Charlottesville
  • USO - Virginia Cancer Specialists, Fairfax
  • VCU Health Adult Outpatient Pavillion, Richmond
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 8. sep. 2026 · NCT06119581

Study to Evaluate Efficacy and Safety of Firmonertinib Compared With Investigator's Choice of EGFR Inhibitor as First-Line Treatment in Participants Who Have Locally Advanced or Metastatic NSCLC With EGFR P-Loop and Alpha C-Helix Compressing (PACC) Uncommon Mutations

  • University of Virginia, Charlottesville
  • Virginia Cancer Specialists, Fairfax
  • Shenandoah Oncology, P.C., Winchester
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 1. sep. 2026 · NCT07185997

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

  • VCU Medical Center (Virginia Commonwealth University), Richmond
RekruttererFase 2
Alder 18 til 70 · Alle kjønn · Oppdatert 26. jun. 2026 · NCT04614103

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.